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The cllixt of trensforming growth l’uctor bctil (TGFB) on the rxprcssion ol’ ii group ol’ liver gcncs bus been invcstiwtcd in thr! hcptitoma cull line 
Hcp 3B. TGF_P inducts i\ ducrcssc of the btisill lrvcl of ;Ipolipoprotcin A-II (ApoA-II). rctinol binding protcin (RBP) und a-fctoprotcin (aFp). 
Furthcrmorc, TGFP cl’ficicntly antagonizes the IL-O-induction ol’hcmopcxin (Hpx) und haptoglobin (Hp) and al-acid glycoprotcin (AGP). Thcsc 
ukts ol’ TCiFp ;1rc i?pp;lrcntly mcdiatcd by post.tr;lns~riptioll;ll mcch;mism(s). Thcsc findings, togcthcr with previously rfportcd datu 611 the 
inhibitory clkct of ‘TGFfi on UCULC phusc gum (e.g. ApoA-I and albumins). suggest a role I‘or TGFP in the rcgulntion of cxprcssion of liver ~CIICS. 
Transforming growth I*xior p; Intcrlcukin-6: Liver ycnc csplcssion: Cytukinc 
1. INTRODUCTION 
Transforming growth factor beta (TGFP) is a multi- 
functional polypeptidc that can modulate growth and 
differentiation of many cell types. It also influences var- 
ious processes in vivo, including early embryo develop 
mcnt, angiogenesis and wound healing [I]. Most of the 
effects exerted by TGFP appear to be consequent tothe 
regulation of the expression of specific genes [2.3]. We 
have lately studied the effect of TGFP on expression 01’ 
liver genes. Expression of several iver genes is altered 
following induction of the acute phase response. This 
results in an increase in the synthesis of scvcral plasma 
proteins like hemopexin, hnptoglobin, C-reactive pro- 
tein, serum amyloid A, the a, p, and y chains of fibri- 
nogen, and in a decrease in the levels of other proteins 
such as albumin, ApoAl and transferrin. Many studies 
have demonstrated that human hepatoma cell lines can 
reproduce the changes in gene expression characteristic 
of the hepalic acuk phase response when stimulated 
with monocyte conditioned medium (MoCM) or with 
purified cytokines [4-61. 
Several cytokines appear in fact to be involved in the 
control of gene expression in the liver: in particular, 
IL-6 upmodulates the expression of genes coding for 
positive acute phase reactants [4--T]. On the contrary in 
Hep 3B cells TGFP down-regulates the mRNA levels of 
genes negatively modulated during liver acute phase 
reaction without stimulating the expression of positive 
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AP gcncs [2]. TGFjI also inhibits the expression of the 
coagulation faclor VII and of both basal and IL-6- 
stimulated cxprcssion of the mRNA of the a, /?, and y 
chains of fibrinogen [3]. An inhibitory effect of TGFB 
on sonic positive acute phase proteins has also been 
described [8.9]. Here we extend our analysis to other 
liver genes. The data we report indicate that TGFB 
dccreascs the expression of ApoA-II, RBP and aFp and 
efficiently counteracts IL-6-stimulated expression of he- 
mopcxin, haptoglobin and AGP 111 Hep 38 cells. Both 
run-on analysis and CAT assays indicate that the effects 
of TGFj3 on the expression of these genes are mostly 
cxertcd at the post-transcriptional level. 
2. MATERIALS AND METHODS 
Hcp 3B cells wart grown in Dulbccco’s minimal csscntiul medium 
(DMEM) supplcmcntcd with 10% f&l CJIT strum (FCS). Monocytu 
conditioned mcdiuln (MoCM) was obttiinud from pcriphcrul blood 
mononuckir cells (PBMC) as dcscribcd [Z]. Rccombintint IL-6 ws 
I’xm Bochriilgcr-Muiinhcim and TGFB-I from R & D, Minnunpolis. 
$2. HNJ prrprrdorr ami N’or’ilrcrw bb~ trmdysis 
RNA wus extracted by guanidium thiocynnatc lysis nnd ullraccn- 
trifuution on CsCl density gradient. Total RNA (20 fig) WIS W- 
p;lr;ucd by clcctrophorcsis on I .3% denaturing agxosc-formdldchydc 
gels und trtinslhrrcd 01110 nylon filters (GcncScrccn Plus. Du Pont- 
NW Englund Nuclcx). Filters &crc hybridized with ‘?-lubckd 
probes and :tutorudiogrnphud ;is described [2). 
DNA transkctions wcrc performed with the calcium phosphiltc 
prccipitntion technique. At’tcr 16 h cells wcrc trypsinizcd. pltitcd on 
scF;lr;ltc dishus and trcutcd with difl‘crcnt stimulunts. Chloroamphcni- 
col xctyltrunsl’cnlsc ussdy WEW pcrt’ormcd as dcscribcd [4.7]. A RSV- 
I 
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luciferase plasmid was included in the trtinsfcctions nscontrol and the 
CAT activity was normtilizcd by compurison with the lucifcrasc uctiv- 
ity of the corresponding s~mplc. The plasmids containing the 5’ rcgu- 
lntory sequence ofhcmopexin (Hpx-175 ;md Hpx-2000) und ofhupto- 
blobin (Hp-186) have been previously described [4,7], 
For transcriptional nnulysis. 4 x IO’ cells were welshed with cold 
PBS. scraped and pelleted. Nuclei wm prqxlred nnd tr:tnscription 
carried out in the prcscncc of p2P]UTP iis described [2,3]. cDNAs 
bound LO nitrocellulose filters were hybridized with 1 x IOh cpmlml of 
radiolabelled nuclcur tmnscripts. 
3. RESULTS 
3. I. EJfect oj’ TGFP ott eqmssiot: oJ’ ctpo fipoFt-orein A- 
l!, rerinol bindittg ptwteitt cttul ctlplrct Jtroproreitr 
Hep 3B cells were treated with MoCM or purified 
porcine TGFB for 48 h. As shown in Fig. 1 treatment 
with MoCM results in a slight decrease of ApoA-I1 
mRNA compared to untreated cells while incubation 
with TGFB-1. from 0.2-j nglml. produced a pro- 
nounced dose-dependent decrease of the ApoA-II 
mRNA. The expression of the mRNA of two other 
genes a-fetoproteina (aFp) and retinol binding protein 





Fig. 1. Effect of TGFj on (A) ApoA-Il. (B) afctoprolcin. (C) rctinol 
binding protein and (9) I’-xtin. Hep 39 cells wcrr cultured for 48 h 
with either 15% MoCM nnd the indicated amount ofTGFB. RNA WBS 
cktracted and hybridized with the specific probes as in Materinls und 
We extended our analysis to genes whose expression 
is stimulated by lL-6 in Hep 3B cells. Addition of 
MoCM to most hcpatoma cell lines results in at least a 
IO-fold increase in the expression of the positively regu- 
lated acute phase genes like haptoglobin, AGP and he- 
mopexin, and a similar effect is observed after treatment 
with IL-6 [4]. Incubation of Hep 3B cells with IL-6 
resulted in an induction of the mRNA for haptoglobin, 
while treatment with TGF/3 at 5 @ml had no effect on 
expression of this gene (Fig. 2). Combined treatment 
with ‘i’C;Fp and IL-6 resulted in almost complete abro- 
gatlon of induction of the haptoglobin mRNA. Similar 
results were observed when expression of hemopexin 
was analyzed. 






Fig. 2. Northern blot analysis of RNA from Hep 3B cells, either 
umrcatcd or after addition of IL-6 (750 U/ml). IL-6 (750 U/ml) + 
TGFB (5 ng/ml) for 48 h, or prc-trc;ltcd for I2 h with IL-6 (750 U/ml) 
or TGF/? (5 ng/ml) nnd then with the other cytokinc. Hp, haptoblobin; 
AGP, al-acid glycoprolcin; Hpx, hcmopcxin; At. a lantitrypsin: PAI- 
I, phtsminogcn wctivulor inhibitor type I. 
Hep 3B cells and not part of the liver acute phase reac- 
tion was also studied. aFp mRNA accumulation was 
also sensitive to both MoCM and TGFj?, which at 2 
@ml completely abrogated aFp mRN.4 expression in 
Hep3B. The expression of REP mRNA was not signiti- 
cantly affected by MoCM but was down-regulated by 
TGF/3, The same RNA preparations were hybridized 
with a y-actin cDNA as internal control. 
3 -2. Atmtgottisric ejrecr of TGFP tit? ILd-itthceci genes 
2 
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are not detectable in unstimulated cells, AGP mRNA 
is expressed in untreated Hcp 35 cells, yet its levels can 
be further increased by addition of IL-6. Treatment 
with TGFP results in both a decrease in the basal evels 
and in a reduction of IL-6-induced expression of AGP. 
No effect on al-antitrypsin was detected in dther con- 
trol Hep 3B cells or in cells treated with TGFB, IL-6 01 
a combination of them, 
Expression of the plasminogen activator inhibitor 
gene type 1 (PAI-I) is known to be regulated by TGFP 
in many cell types. We therefore tested whether contem- 
porary treatment with IL-6 would affect TGFP induc- 
tion of this gene. As shown in panel E, IL-6 did not 
affect induction by TGFP of PAI-I. It has been reported 
[9] that pre-treatment of PCL/PRF/S cells with TGF/? 
followed by incubation with IL-6 increased the synthc- 
sis of C-reactive protein (CRP), whereas pre-treatment 
with IL-B followed by TGFB or co-treatment with the 
two cytokines both resulted in a dramatic decrease of 
CRP production. In our experiments as shown in Fig. 
2, pre-treatment of Hcp 3B cells with either cytokine 
and addition of the other I2 h later (lanes 5-6) did not 
show significant differences compared with co-treal- 
ment with both molecules (lane 4) for all the mRNAs 
analyzed. 
3.3. I%rp acts ruairtly NC rlre posr-r~rrrtsc~i~)tiortai hel it1 
wgthfirtg Iiw gerte e.ymmion itt ffep 3B cells 
To analyze the effect of TGFP on the transcription 
of the AGP and RBP genes the neo-synthesis of RNA 
was measured in isolated nuclei. The rate of transcrip- 
tion of the AGP gene but not of RBP was stimulated by 
MoCM (Fig. 3). Treatment with TGF;B did not affect 
transcription of AGP and RBP although TGFB signifi- 
cantly diminished the accumulation of these mRNA as 
evaluated by Northern analysis (Fig. I). As previously 
reported albumin transcription was reduced by around 
Z-fold following TGFP treatment. 
In preliminary experimenrs we observed that analysis 
of chloramphenicol acetyhransferase (CAT) activity, in 
cells transfected with plasmids containing the promoter 
region of hemopexin and haptoglobin fused to the cod- 
ing region of the bacterial CAT gene, was a better assay 
for transcriptional regulation by IL-6 than run-on as- 
says for genes whose regulatory regions have been ex- 
tensively characterized, such as hemopexin and hapto- 
globin [4,7]. To evaluate whether TGFP exerted an inhi- 
Tiiblc I 
Induction rates of transfeclcd Hpx- and HpCAT plasmids in 
Hcp 3B cells 
Tcmplalc Control IL-6 TG l=fi I L-6+?GF/3 
Hpx-175 8 2 6 
HPX.2000 I 20 4 I4 
Hp-I86 I 5.5 0.9 4.2 
.- 
CTR M0CM TGFB 
Fig. 3. Nuhr run-on assay prformed on control, MoCM- and 
TGFP-treated Hcp 3B cells. Plusmids wcrc fixed to nitrocellulose 
filters and hybridized with I x IO” cpm/ml or radiolabcllcd nuclear 
transcripts, pDR322 was used as background control. (a) y-actin: (b) 
AGP; (cl RBP: (d) ccl-anlitrypyin; (c) pBR322; (0 albumin. 
bitory effect at the transcriptional or post-transcrip- 
tional (e.g. stability of the mRNA) level. plasmids con- 
taining a segment of the 5’ non-coding regulatory se- 
quence of the haptoglobin and the hemopexin cloned in 
front of the CAT gene were transfected in Hep 3B cells. 
Cells were then treated with IL-6, TGF/?, or a combina- 
tion of both for 48 h, protein extracts prepared and 
CAT activity determined (Table I). A strong IL-6 de- 
pendent stimulation of CAT activity from these con- 
structs was observed. However no major difference was 
observed in CAT activity in cells treated with IL-6 and 
IL-B/TGF,& This suggests that the reduction in mRNA 
levels induced by TGF/3. but not those induced by IL-6, 
are not mediated at the transcriptional lcvcl, but rather 
post-transcriptionally. 
4. DISCUSSION 
Human plasma protein synthesis in liver cell cultures 
is regulated by several cytokines including IL-l-,& IL-6, 
and TNF-a at the gene level [2.4-61. We have previously 
reported that TGF,B down-regulates the mRNA level of 
genes which are negatively modulated uring the acute 
phase reaction (e.g. albumin and ApoA-I) [2]. This ef- 
fect of TGFP contrasts with the ability of IL-6 to stim- 
ulate expression of several positively regulated acute 
phase gents. suggesting that TGFfi and IL-6 may have 
opposite effects in the physiological regulation of these 
two gtoups uf genes. TGFB and IL-6 can also affect the 
expression of a set of proteins involved in coagulation 
[3]. In this context TGFB efficiently counteracts the 
IL-B-induced increase of fibrinogen mRNA and down- 
regulates the basal expression of fibrinogen and factor 
VII mRNA in Hep 3B cells [3]. 
The dat;: p:er;t:tcd berc he!p to better define the role 
of TGFB in the regulation of liver gene expression. 
TGF/? appears to abolish expression of several genes 
3 
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expressed in basal conditions in Hep 3B cells (like AGP 
and RBP) and also inhibits IL-6hduced expression of 
fibrinogen, hup!oglobin. hemopexin and AGP. On the 
other hand IL-6 does not interfere with the expression 
of PAI-I gene induced by TGFP, In accordance with 
our earlier findings on ApoA-I and albumin gene trans- 
cription most of the effects of TGF,!3 in down- regulating 
the expression of the above reported genes appears, by 
either transfection experiments or run-on analysis, to be 
mediated mostly at the post-transcriptional level. 
These results, together with previous findings. show 
that TGFP can regulate the expression of a number of 
liver specific genes. The ability to down-rcgulatc both 
genes constantly expressed in liver as well us genes 
which are stimulated by IL-6 in consistent with the pro- 
posed role of TGFP in the intlammatory and immu- 
nological responses to injury, infection und wound re- 
pair [IO]. 
.,l~~rrt,~~,/c,~!~e,rle,ll.~: WC tllilnk ProC L. Pliilipsoli Ibr continuous sup- 
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